| Metadata | Details |
|---|
| Publication Date | 2025-10-20 |
| Journal | ACS Omega |
| Authors | Azka Muhammad Nurrahman, Prastika Krisma Jiwanti, Mai Tomisaki, Ilma Amalina, Qonita Kurnia Anjani |
| Institutions | Queen’s University Belfast, Nanomaterials Research (United States) |
| Analysis | Full AI Review Included |
- Innovation: A novel AuNP-BDDNP nanocomposite was synthesized and used to modify a screen-printed electrode (SPE) for highly sensitive, selective electrochemical detection of theophylline.
- Performance: Achieved a low limit of detection (LOD) of 0.14 µM and limit of quantification (LOQ) of 0.48 µM across a linear range of 20-140 µM (R2 = 0.999), outperforming many prior electrochemical theophylline sensors.
- Selectivity & Stability: Excellent discrimination against interferents (caffeine, theobromine, ascorbic acid) with strong reproducibility (%RSD = 0.582% over 7 days).
- Microneedle Integration: PVA/PVP microneedles (11 × 11 mm, 600 µm height) were integrated with the modified SPE for minimally invasive interstitial-fluid sampling, maintaining strong signal-to-background ratio (S/B ≈ 6.44 after integration vs. 6.54 prior).
- Real-Sample Validation: Recovery rates of 92.5-107.7% achieved in human urine, coffee, and pharmaceutical capsule samples (Theobron, 130 mg theophylline).
- Materials Foundation: Boron-doped diamond nanoparticles (BDDNP, 0-250 nm) supplied the carbon-matrix advantages — wide potential window, low background current, and chemical inertness — that complement the catalytic activity of the AuNPs.
| Parameter | Value | Unit | Context |
|---|
| Theophylline linear range | 20-140 | µM | DPV linearity analysis |
| Limit of Detection (LOD) | 0.14 | µM | DPV electrochemical measurement |
| Limit of Quantification (LOQ) | 0.48 | µM | DPV electrochemical measurement |
| Correlation coefficient (R2) | 0.999 | — | Linearity of calibration curve |
| Reproducibility (%RSD) | 0.582 | % | Over 7 consecutive days |
| Signal-to-Background ratio (S/B) — pre-MN | 6.54 | — | Bare AuNP-BDDNP/SPE |
| Signal-to-Background ratio (S/B) — post-MN | 6.44 | — | After microneedle integration |
| CV scan rate range | 100, 120, 140, 160, 180, 200 | mV/s | Cyclic voltammetry parameters |
| CV potential window | −1.0 to +1.0 | V (vs Ag/AgCl) | Standard measurement window |
| DPV potential window | 0.0 to +1.5 | V (vs Ag/AgCl) | Theophylline detection |
| DPV step potential | 0.012 | V | Pulse parameters |
| DPV pulse amplitude | 0.05 | V | Pulse parameters |
| DPV pulse time | 0.05 | s | Pulse parameters |
| EIS frequency range | 0.1 - 100,000 | Hz | EIS characterization |
| EIS Edc | 0.2 | V | DC bias |
| EIS Eac | 0.006 | V | AC perturbation |
| AuNP absorbance peak | 520 | nm | UV-vis SPR signature |
| BDDNP sp2 carbon peak | 294 | nm | UV-vis signature |
| AuNP size range | 9 - 32 | nm | TEM analysis |
| AuNP average size | 19.723 | nm | TEM analysis |
| BDDNP size range | 0 - 250 | nm | Supplier spec (Hunan Boromond) |
| Au:BDDNP synthesis mass ratio | 1:1 | — | HAuCl4·3H2O : BDDNP |
| HAuCl4·3H2O concentration | 1 | mM | Precursor solution |
| Na3C6H5O7 concentration | 38.8 | mM | Reducing/capping agent |
| Synthesis temperature | 100 | °C | Boiling reduction |
| Synthesis stirring time | 15 | min | After citrate addition |
| Drying temperature (powder) | 80 | °C | Oven drying, 24 h |
| SPE modification volume | 6 | µL | Drop-cast on working electrode |
| Modification drying temp | 65 | °C | Oven, 10 min |
| Optimal pH | 7 | — | PBS buffer optimization |
| Microneedle array dimension | 11 × 11 | mm | PVA/PVP patch |
| Microneedle height | 600 | µm | Penetration depth |
| Real sample recovery (AuNP-BDDNP/SPE, 120 µM) | 98.6 / 96.1 / 92.5 | % | Urine / Coffee / Capsule |
| Real sample recovery (MNs/AuNP-BDDNP/SPE, 120 µM) | 99.3 / 99.3 / 102.7 | % | Urine / Coffee / Capsule |
| Real sample recovery (MNs/AuNP-BDDNP/SPE, 80 µM) | 102.3 / 93.6 / 107.7 | % | Urine / Coffee / Capsule |
- BDDNP-Au Nanocomposite Synthesis (AuNP-BDDNP)
- Dissolve 0.0098 g HAuCl4·3H2O in 25 mL distilled water (1 mM).
- Add 0.0098 g BDDNP powder (0-250 nm).
- Heat to boiling (100 °C) under stirring.
- Rapidly add 2.5 mL of 38.8 mM trisodium citrate (Na3C6H5O7).
- Color shift light yellow → purple confirms AuNP formation; stir additional 15 min.
- Cool to room temperature; centrifuge, wash with ethanol + water; dry at 80 °C for 24 h.
- Grind to powder using pestle and mortar.
- SPE Modification
- Drop-cast 6 µL of AuNP-BDDNP suspension onto the carbon working electrode.
- Dry at 65 °C for 10 min in oven.
- Characterization
- FESEM-EDX (JEOL JSM-7900F) for morphology and elemental confirmation (Au, B, C).
- TEM (JEOL JEM-ARM200F) for particle size distribution (9-32 nm range).
- UV-vis spectrophotometry for SPR peak confirmation (520 nm).
- XPS (PHI 5000 VersaProbe II) for surface chemistry.
- EIS: 0.1-100,000 Hz, Edc 0.2 V, Eac 0.006 V.
- CV: −1.0 to +1.0 V, scan rates 100-200 mV/s.
- Electrochemical Detection of Theophylline
- DPV from 0.0 to +1.5 V (vs Ag/AgCl); step 0.012 V; pulse amplitude 0.05 V; pulse time 0.05 s; scan rate 50 mV/s.
- Selectivity tested against caffeine, theobromine, ascorbic acid (1:1 v/v, potential window extended to −0.3 V).
- Microneedle (MN) Integration
- PVA/PVP microneedle patches (11 × 11 mm, 600 µm height, citric acid cross-linked for 3 h).
- Wash MNs in ethanol/water ultrasonic bath.
- Immerse MNs in theophylline standard solution.
- Place immersed MNs onto AuNP-BDDNP/SPE; wrap tightly with Parafilm to simulate interstitial fluid uptake.
- Real-Sample Protocol
- Urine (morning sample, undiluted).
- Coffee (powder mixed with 300 mL water).
- Theobron capsule (130 mg theophylline dissolved in 721 mL water → 1 mM; diluted in 0.1 M PBS pH 7).
- Spiked at 80 µM and 120 µM; n = 3 replicates per measurement.
- Applicable Materials:
- Heavy Boron-Doped Diamond Nanoparticles (BDDNP): 6CCVD can supply BDD nanopowder in the 0-250 nm particle-size window used in this study. Our BDDNP inherits the same advantageous electrochemical profile — wide potential window, low background current, and chemical inertness — making it a drop-in replacement for the starting nanomaterial.
- Optical/ Electronic Grade SCD and Polycrystalline BDD Wafers: For researchers looking to migrate from drop-cast SPE modification to integrated thin-film BDD working electrodes, our freestanding BDD wafers (polished Ra < 5 nm for inch-size PCD) can be patterned via laser cutting to match custom electrode geometries.
- Customization Potential:
- Custom Electrode Geometries: Laser-cut BDD wafers and patterned substrates allow replication of the SPE architecture with enhanced intrinsic electrochemical performance.
- Custom Metalization (Au, Pt, Pd, Ti, W, Cu): 6CCVD’s in-house metallization capability supports direct deposition of conductive contacts onto BDD — eliminating the need for adhesive silver pastes and enabling miniaturized, implantable-grade sensor layouts suited for microneedle integration.
- Boron-Level Tuning: Boron concentration can be specified from low (1018 cm−3) to heavy (1021 cm−3) doping to optimize conductivity versus sp2 content for nanoparticle applications.
- Wafer-to-Powder Continuity: If scaling from lab-scale nanoparticle-modified SPEs to wafer-level thin-film electrodes is desired, 6CCVD provides both the wafer feedstock (BDD, SCD, PCD) and BDD nanopowder from the same supply chain.
- Engineering Support:
- 6CCVD’s in-house PhD engineering team can assist with material selection for wearable / microneedle-integrated electrochemical sensors, including guidance on boron-doping levels, sp2/sp3 ratios for SPR-active substrates, and Au-nanoparticle compatibility. We support both academic proof-of-concept and pilot-scale manufacturing pathways.
- Call to Action:
- For custom specifications, boron-doping consultation, metallization design, or laser-patterned electrode prototyping, visit 6ccvd.com or contact our engineering team directly.
View Original Abstract
Theophylline is a drug with a narrow therapeutic index, with normal plasma levels ranging from 10 to 20 mg/L. Theophylline overdose can lead to several symptoms, including nausea, vomiting, headaches, pancreatitis, and death. Thus, it is important to monitor theophylline after its consumption. Microneedles (MNs) can be integrated with screen-printed electrodes (SPE) to enable the minimally invasive monitoring of theophylline. In this study, we developed a highly sensitive and accurate electrochemical sensor to detect theophylline based on a gold nanoparticle/boron-doped diamond nanoparticle nanocomposite-modified SPE (AuNP-BDDNP/SPE). In addition, this study aims to determine the feasibility of MN integration with AuNP-BDDNP/SPE for theophylline detection. UV-vis, TEM, and XPS confirmed the successful synthesis of AuNP-BDDNP, whereas FESEM images confirmed the successful modification of SPE. Theophylline detection was performed using differential pulse voltammetry (DPV) with concentrations ranging from 20 to 140 μM, producing an <i>R</i> <sup>2</sup> value of 0.999, an LOD of 0.14 μM, and an LOQ of 0.48 μM. AuNP-BDDNP/SPE was also selective in the presence of interferents. AuNP-BDDNP/SPE can accurately detect theophylline in urine, coffee, and capsule samples. Moreover, AuNP-BDDNP/SPE was successfully integrated with MNs, maintaining the accuracy for detecting theophylline in urine, coffee, and capsule samples. AuNP-BDDNP/SPE demonstrated excellent performance in theophylline detection and can potentially be successfully integrated with MNs.